Article Details

AstraZeneca and Sanofi secure EU approval for antibody to prevent RSV in infants

Retrieved on: 2022-11-04 11:08:52

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca and Sanofi secure EU approval for antibody to prevent RSV in infants. View article details on hiswai:

Excerpt

AstraZeneca and Sanofi's Beyfortus (nirsevimab) has been approved in the EU the prevention of respiratory syncytial virus (RSV) lower respiratory ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up